Literature DB >> 7526198

Intracellular localization and function of DNA repair methyltransferase in human cells.

T Ishibashi1, Y Nakabeppu, H Kawate, K Sakumi, H Hayakawa, M Sekiguchi.   

Abstract

An antibody preparation specific for human O6-methylguanine-DNA methyltransferase (EC 2.1.1.63) was obtained by immunoaffinity purification on two types of affinity columns with the purified human and mouse methyltransferase proteins as ligands. The antibodies were used in Western blotting analysis of fractionated cell extracts. More than 90% of the methyltransferase protein was recovered in the cytoplasmic fractions with both human HeLa S3 cells and MR-M cells, the latter overproducing the enzyme 36 times as much as the former. Cytoplasmic localization of the methyltransferase in HeLa S3 cells was further confirmed by in situ immunostaining. By Western blotting analysis of fractionated cell extracts from HeLa S3 cells treated with alkylating agents, we found that amounts of the enzyme decreased more rapidly in the nuclear fraction than in the cytoplasmic fraction, and recovery of the enzyme level in the cytoplasmic fraction was slower than that in the other. These results suggest that the methyltransferase protein is degraded in the nucleus after it commits the repair reaction and that the cytoplasmic enzyme is transported into the nucleus as the nuclear methyltransferase is used up in this manner.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526198     DOI: 10.1016/0921-8777(94)90032-9

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  8 in total

1.  Human APE2 protein is mostly localized in the nuclei and to some extent in the mitochondria, while nuclear APE2 is partly associated with proliferating cell nuclear antigen.

Authors:  D Tsuchimoto; Y Sakai; K Sakumi; K Nishioka; M Sasaki; T Fujiwara; Y Nakabeppu
Journal:  Nucleic Acids Res       Date:  2001-06-01       Impact factor: 16.971

2.  Recombinant human O6-alkylguanine-DNA alkyltransferase (AGT), Cys145-alkylated AGT and Cys145 --> Met145 mutant AGT: comparison by isoelectric focusing, CD and time-resolved fluorescence spectroscopy.

Authors:  M Federwisch; U Hassiepen; K Bender; M Dewor; M F Rajewsky; A Wollmer
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

3.  The nuclear targeting and nuclear retention properties of a human DNA repair protein O6-methylguanine-DNA methyltransferase are both required for its nuclear localization: the possible implications.

Authors:  A Lim; B F Li
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

4.  Expression of O-Alkylguanine-DNA Alkyltransferase in Normal and Malignant Bladder Tissue of Egyptian Patients.

Authors:  Abir A Saad; Heba Sh Kassem; Andrew C Povey; Geoffrey P Margison
Journal:  J Nucleic Acids       Date:  2010-10-17

Review 5.  DNA-repair methyltransferase as a molecular device for preventing mutation and cancer.

Authors:  M Sekiguchi; Y Nakabeppu; K Sakumi; T Tuzuki
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

6.  Human AP endonuclease 1 (HAP1) protein expression in breast cancer correlates with lymph node status and angiogenesis.

Authors:  S Kakolyris; L Kaklamanis; K Engels; S B Fox; M Taylor; I D Hickson; K C Gatter; A L Harris
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

7.  Protein sensing in living cells by molecular rotor-based fluorescence-switchable chemical probes.

Authors:  Wan-Ting Yu; Ting-Wei Wu; Chi-Ling Huang; I-Chia Chen; Kui-Thong Tan
Journal:  Chem Sci       Date:  2015-10-01       Impact factor: 9.825

8.  The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance.

Authors:  Florian A Siebzehnrubl; Daniel J Silver; Bugra Tugertimur; Loic P Deleyrolle; Dorit Siebzehnrubl; Matthew R Sarkisian; Kelly G Devers; Antony T Yachnis; Marius D Kupper; Daniel Neal; Nancy H Nabilsi; Michael P Kladde; Oleg Suslov; Simone Brabletz; Thomas Brabletz; Brent A Reynolds; Dennis A Steindler
Journal:  EMBO Mol Med       Date:  2013-07-01       Impact factor: 12.137

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.